ScreenPro Security Inc. (SCRSF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.24 Million USD | 41.96% |
| 2022 | -3.87 Million USD | 51.75% |
| 2021 | -8.02 Million USD | -14043.07% |
| 2020 | -56.77 Thousand USD | -40.42% |
| 2019 | -40.43 Thousand USD | 47.41% |
| 2018 | -76.87 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -90.57 Thousand USD | -23.69% |
| 2024 Q2 | -22.37 Thousand USD | 75.1% |
| 2023 Q3 | -804.87 Thousand USD | -22.32% |
| 2023 Q2 | -658.03 Thousand USD | 2.78% |
| 2023 FY | -2.24 Million USD | 41.96% |
| 2023 Q1 | -676.86 Thousand USD | -145.9% |
| 2023 Q4 | -74.96 Thousand USD | 90.69% |
| 2022 Q4 | -275.26 Thousand USD | 81.05% |
| 2022 FY | -3.87 Million USD | 51.75% |
| 2022 Q3 | -1.45 Million USD | 26.21% |
| 2022 Q2 | -1.96 Million CAD | -637.73% |
| 2022 Q1 | -266.79 Thousand CAD | 94.07% |
| 2021 Q2 | 140.48 Thousand CAD | 103.88% |
| 2021 Q1 | -3.62 Million CAD | -10452.7% |
| 2021 Q3 | 570.88 Thousand CAD | 306.37% |
| 2021 FY | -8.02 Million USD | -14043.07% |
| 2021 Q4 | -4.49 Million USD | -887.71% |
| 2020 Q3 | -12 Thousand CAD | 0.0% |
| 2020 Q1 | -14 Thousand CAD | -3.58% |
| 2020 FY | -56.77 Thousand USD | -40.42% |
| 2020 Q4 | -34.33 Thousand CAD | -186.1% |
| 2020 Q2 | -12 Thousand CAD | 14.29% |
| 2019 Q4 | -13.51 Thousand CAD | -2.28% |
| 2019 FY | -40.43 Thousand USD | 47.41% |
| 2019 Q3 | -13.21 Thousand CAD | -10.47% |
| 2019 Q2 | -11.96 Thousand CAD | 12.9% |
| 2019 Q1 | -13.73 Thousand CAD | 0.0% |
| 2018 FY | -76.87 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -59.487% |
| Arrayit Corporation | -3.31 Million USD | 32.176% |
| Atlantic International Corp. | -5.62 Million USD | 60.04% |
| Biocept, Inc. | -32.08 Million USD | 92.992% |
| Bioqual, Inc. | 483.48 Thousand USD | 565.12% |
| CardioGenics Holdings Inc | -1.91 Million USD | -17.348% |
| DermTech, Inc. | -100.88 Million USD | 97.771% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.111% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 89.586% |
| iMD Companies, Inc. | -200.63 Thousand USD | -1020.819% |
| IDenta Corp. | 14.64 Thousand USD | 15456.235% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 380.395% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 5912.42% |
| InVitro International | 1553.00 USD | 144901.481% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 73.827% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -3769.712% |
| Medical Imaging Corp. | -3.02 Million USD | 25.612% |
| NovelStem International Corp. | -4.18 Million USD | 46.296% |
| Optigenex Inc. | -2.89 Million USD | 22.396% |
| PharmChem, Inc. | 845.1 Thousand USD | 366.094% |
| Proteome Sciences plc | -2.44 Million USD | 7.951% |
| Response Genetics, Inc | -20.18 Million USD | 88.859% |
| Rennova Health, Inc. | -3.29 Million USD | 31.712% |
| RushNet, Inc. | -607.02 Thousand USD | -270.455% |
| Stella Diagnostics Inc. | -5.7 Million USD | 60.599% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 80.301% |
| Todos Medical Ltd. | -24.99 Million USD | 91.003% |